Ocular toxicity and tolerability of BCMA directed antibody drug conjugate (ADC) therapy in relapsed multiple myeloma (MM).

Authors: Matthew J. Rees, Timothy T. Xu, Suheil Albert Atallah-Yunes, Kenneth J. C. Lim, Angela Dispenzieri, Morie A. Gertz, Taxiarchis Kourelis, Eli Muchtar, Rafael Fonseca, Ricardo Daniel Parrondo, Sikander Ailawadhi, Peter Leif Bergsagel, Wilson I. Gonsalves, David Dingli, Francis Buadi, S. Vincent Rajkumar, Prashant Kapoor, Jithma P. Abeykoon, Sanjay Patel, Shaji Kumar

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e19503

Source: Full article


Abstract

e19503